title: Dramatic reduction of chronic lymphoedema of the lower limb with sorafenib therapy.
abstract: This paper describes an interesting case report based on a patient who had a dramatic and astounding reduction in her chronic lymphoedema while on sorafenib.
authors.affiliation: Sydney Melanoma Unit, North Sydney, New South Wales, Australia. marc@moncrieff.net
authors.forename: Marc
authors.initials: M
authors.lastname: Moncrieff
authors.forename: Kerwin
authors.initials: K
authors.lastname: Shannon
authors.forename: Angela
authors.initials: A
authors.lastname: Hong
authors.forename: Peter
authors.initials: P
authors.lastname: Hersey
authors.forename: John
authors.initials: J
authors.lastname: Thompson
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D035002:Lower Extremity; D008207:Lymphatic Metastasis; D008209:Lymphedema / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D008545:Melanoma / Q000532:radiotherapy / Q000556:secondary* / Q000601:surgery; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use*; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib